|
2B0304
|
6505-01-157-3716
|
Usp Sterile Water For Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0013-04
|
6505-01-157-3716
|
Usp Sterile Water For Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00641-2555-45
|
6505-01-157-4196
|
Usp Phenytoin Sodium Injection |
Elkins-sinn Inc
|
|
Quote
|
|
NDC00469-1615-25
|
6505-01-157-4196
|
Usp Phenytoin Sodium Injection |
Astellas Pharma Us, Inc.
|
|
Quote
|
|
NDC00467-1615-25
|
6505-01-157-4196
|
Usp Phenytoin Sodium Injection |
Invenex Laboratories
|
|
Quote
|
|
NDC00646-0640-20
|
6505-01-157-4826
|
Immune In Maltose Injec Globulin |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00646-0640-20
|
6505-01-157-4826
|
Immune In Maltose Injec Globulin |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00517-5710-25
|
6505-01-157-5115
|
Usp Furosemide Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
NDC00074-6102-11
|
6505-01-157-5115
|
Usp Furosemide Injection |
Abbott Laboratories
|
|
Quote
|
|
NDC00186-1114-13
|
6505-01-157-5116
|
Usp Furosemide Injection |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC00517-5702-01
|
6505-01-157-5116
|
Usp Furosemide Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
NDC00641-0382-24
|
6505-01-157-5116
|
Usp Furosemide Injection |
Elkins-sinn Inc
|
|
Quote
|
|
NDC00469-7500-10
|
6505-01-157-5116
|
Usp Furosemide Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00517-5702-25
|
6505-01-157-5117
|
Usp Furosemide Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
NDC23155-0473-41
|
6505-01-157-5117
|
Usp Furosemide Injection |
Heritage Pharmaceuticals Inc
|
|
Quote
|
|
NDC00409-6102-01
|
6505-01-157-5117
|
Usp Furosemide Injection |
Hospira, Inc.
|
|
Quote
|
|
28002
|
6505-01-157-5117
|
Usp Furosemide Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
NDC63323-0280-02
|
6505-01-157-5117
|
Usp Furosemide Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
RESTORIL
|
6505-01-157-5987
|
Temazepam Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
RESTORIL CAPSULES
|
6505-01-157-5987
|
Temazepam Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
RESTORIL SANDOPAK
|
6505-01-157-5987
|
Temazepam Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0098-06
|
6505-01-157-5987
|
Temazepam Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
6505-LL-L00-3022
|
6505-01-157-5988
|
Temazepam Capsules |
Defense Logistics Agency
|
|
Quote
|
|
RESTORIL SANDOPAK
|
6505-01-157-5988
|
Temazepam Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0099-06
|
6505-01-157-5988
|
Temazepam Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC10481-3001-04
|
6505-01-157-6876
|
Urea Cream |
Dercher Enterprises Inc
|
|
Quote
|
|
QUINAGLUTE
|
6505-01-157-7622
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC50419-0101-50
|
6505-01-157-7622
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00378-9112-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NITRODISC
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC49730-0122-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Hercon Company, Inc
|
|
Quote
|
|
NDC00089-0303-02
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00089-1303-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
3m Company Health Care/mfg
|
|
Quote
|
|
NDC00904-5496-46
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00025-2068-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC54092-0344-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
NDC62794-0204-93
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Mylan Bertek Pharmaceuticals Inc
|
|
Quote
|
|
NDC00085-3320-30
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-3320-35
|
6505-01-157-9064
|
Nitroglycerin Transdermal System |
Schering-plough Corporation
|
|
Quote
|
|
NORPACSE CR
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2732-31
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2732-31
|
6505-01-158-2170
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
RENALYTE RX 119
|
6505-01-158-3297
|
Concentrat Hemodialysis Solution |
Cobe Laboratories Inc
|
|
Quote
|
|
12-119-055
|
6505-01-158-3297
|
Concentrat Hemodialysis Solution |
Cobe Laboratories Inc
|
|
Quote
|
|
NDC00603-5168-21
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC63304-0744-01
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Ranbaxy Pharmaceuticals Inc
|
|
Quote
|
|
NDC54868-3381-00
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Medical and Safety Group Inc
|
|
Quote
|
|
NDC00054-8707-25
|
6505-01-158-3628
|
Usp Phenobarbital Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
EVAC-Q-KWIK
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00281-0297-76
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00013-2189-00
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Erbamont Inc
|
|
Quote
|
|
EVAC-Q-KWIK
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00281-0297-76
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Savage Laboratories Div of Altana
|
|
Quote
|
|
NDC00013-2189-00
|
6505-01-158-4346
|
Preradiographic Exa Laxative Kit |
Erbamont Inc
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-2742-31
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NORPACE CR
|
6505-01-158-6361
|
Disopyramide Phosphate Extended |
Searle G D and Co
|
|
Quote
|
|
NDC00002-1691-25
|
6505-01-158-6811
|
Usp Protamine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1691-25
|
6505-01-158-6811
|
Usp Protamine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1691-25
|
6505-01-158-6811
|
Usp Protamine Sulfate Injection |
Eli Lilly and Company
|
|
Quote
|
|
LANATUSS EXPECTORANT
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
NDC00527-0808-28
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
LANATUSS EXPECTORANT
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
NDC00527-0808-28
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
LANATUSS EXPECTORANT
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
NDC00527-0808-28
|
6505-01-158-6812
|
Guaifen Chlorpheniramine Maleate |
Lannett Company, Inc.
|
|
Quote
|
|
TRAVASOL 10%
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
1A6626
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0629-06
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
TRAVASOL 10%
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
1A6626
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0629-06
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
TRAVASOL 10%
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
1A6626
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0629-06
|
6505-01-158-6813
|
Amino Acid Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC01490-0039-04
|
6505-01-158-7615
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
CYTOXAN
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NEOSAR
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
NDC00015-0505-41
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00013-5636-70
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
CYTOXAN
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NEOSAR
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
NDC00015-0505-41
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00013-5636-70
|
6505-01-158-7889
|
U Cyclophosphamide For Injection |
Erbamont Inc
|
|
Quote
|
|
NDC00407-0044-01
|
6505-01-158-8001
|
Metrizamide For Injection |
Ge Healthcare Inc.
|
|
Quote
|
|
NDC00407-0044-01
|
6505-01-158-8001
|
Metrizamide For Injection |
Amersham Health Inc.
|
|
Quote
|
|
STREPTASE
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
NDC00053-1770-01
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
STREPTASE
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
NDC00053-1770-01
|
6505-01-158-8002
|
Streptokinase For Injection |
Asd Specialty Healthcare, Inc.
|
|
Quote
|
|
METOPIRONE
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-0130-11
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
METOPIRONE
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-0130-11
|
6505-01-158-8003
|
Usp Metyrapone Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
5M7066
|
6505-01-159-0474
|
Concentrat Hemodialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
DIASOL
|
6505-01-159-0474
|
Concentrat Hemodialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
